⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22046799 | 0.56 | — | — | |
| SCHEMBL28355 | 0.47 | — | — | |
| SCHEMBL8748857 | 0.47 | — | — | |
| Lithium Ion SCHEMBL31168143 | 0.47 | — | — | |
| SCHEMBL18485887 | 0.47 | — | — | |
| SCHEMBL15547702 | 0.47 | — | — | |
| SCHEMBL19674964 | 0.45 | — | — | |
| SCHEMBL15031077 | 0.45 | — | — | |
| SCHEMBL1846761 | 0.42 | — | — | |
| Bromide SCHEMBL11176937 | 0.42 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3660508-B1 | GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES | CELERA CORP (US) | 2021-08-18 | — | — | EP | disclosed |
| EP-3048175-B1 | GENETIC POLYMORPHISM ASSOCIATED WITH STROKE, THERAPY BASED ON THE DETECTION OF THE POLYMORPHISM AND USE OF KITS CONTAINING REAGENTS FOR DETECTING THE POLYMORPHISM | CELERA CORP (US) | 2018-05-16 | — | — | EP | disclosed |